Riskpilot← Back to searchSign inGet full accessI Larsson Läkarkonsult AB
ABDissolvedOrg 5590011085Medical specialists activities · NACE 8622Est. 20150 employees
Revenue 2020
SEK 0
EBITDA margin
—
-150% vs 2019
Equity ratio
98.3%
Financial strength
Net profit 2020
SEK -15K
-150% vs 2019
| Revenue | SEK 0 | — |
| EBITDA | SEK -15K | -150% |
| Net profit | SEK -15K | -150% |
| Total assets | SEK 180K | -51% |
| Equity | SEK 177K | -52% |
| Employees | 0 | — |
Legal name
I Larsson Läkarkonsult AB
Org number
5590011085
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
20 januari 2015
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Company purpose
Tillhandahålla läkartjänster
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 905 | 391 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 651 | 28 | −13 | −6 | −15 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 651 | 28 | −13 | −6 | −15 |
| Net financials | — | — | — | — | — |
| Profit before tax | 651 | 29 | −13 | −6 | −15 |
| Tax | −144 | −7 | −0 | −0 | −0 |
| Net profit | 507 | 22 | −13 | −6 | −15 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 999 | 732 | 549 | 371 | 180 |
| Equity | 871 | 729 | 547 | 369 | 177 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 129 | 3 | 2 | 2 | 3 |
| Total debt | 129 | 3 | 2 | 2 | 3 |
EBITDA margin
-1500000.0%
This company
15.8%
Market median
-9493771% vs market
20162020
Equity ratio
98.3%
This company
38.2%
Market median
+157% vs market
20162020
Return on equity
-8.5%
This company
18.4%
Market median
-146% vs market
20162020
Net profit margin
-1500000.0%
This company
8.1%
Market median
-18518619% vs market
20162020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162020
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20162020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
| Former (2) | ||
| Board of Directors | 2021 – 2021 | |
| Deputy Board Member | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of I Larsson Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva-Lena Birgitta Johansson Olsson | Deputy Board Member | 0 companies |
| Karl Johan Stefan Bratteberg | Board of Directors | 0 companies |
| Ingrid Mariann Larsson | Board of Directors | 0 companies |
| Therese Anna Maria Bratteberg | Deputy Board Member | 0 companies |
| Emma Maria Gonzalez Larsson | Deputy Board Member | 0 companies |